Table 3

The effect of pooled exercise interventions on body weight, waist circumference, blood pressure, lipid and glucose metabolism compared with the control group

VariableMean (SE)*Pooled intervention versus
CON change from baseline to 6 years†
P for group × FH intertaction term
Control group (CON)
(n=782)
Pooled intervention group (n=275)
Baseline6 yearsBaseline6 yearsMean (95% CI)*P valueGroupFHInteraction
Weight (kg)82.0 (0.5)83.2 (0.5)82.4 (0.9)83.0 (0.9)−0.5 (−1.4 to 0.4)0.2720.4640.1480.147
Waist circumference (cm)93.9 (0.4)96.1 (0.4)94.7 (0.7)96.2 (0.7)−0.7 (−1.5 to 0.2)0.1460.1990.0460.31
Body mass index (kg/m2)28.0 (0.1)28.4 (0.2)28.0 (0.3)28.3 (0.2)−0.2 (−0.5 to 0.1)0.3220.5850.1890.176
Systolic BP (mm Hg)134.8 (0.7)139.7 (0.7)133.4 (1.0)133.9 (1.0)−4.8 (−6.7 to −3.0)<0.001<0.0010.4120.218
Diastolic BP (mm Hg)84.0 (0.4)79.8 (0.4)81.4 (0.6)75.3 (0.6)−2.9 (−4.0 to −1.9)<0.001<0.0010.6960.477
Triglycerides (mmol/L)1.5 (0.03)1.5 (0.03)1.4 (0.05)1.4 (0.05)−0.1 (−0.2 to 0.01)0.0970.1640.8540.979
Total cholesterol (mmol/L)5.5 (0.04)5.5 (0.04)5.5 (0.1)5.6 (0.1)0.1 (0.004 to 0.2)0.0420.0290.9920.07
HDL-cholesterol (mmol/L)1.3 (0.01)1.3 (0.01)1.3 (0.02)1.4 (0.03)0.1 (0.03 to 0.1)0.0010.0040.4050.842
LDL-cholesterol (mmol/L)3.5 (0.03)3.5 (0.04)3.6 (0.1)3.6 (0.1)0.1 (−0.02 to 0.2)0.1030.050.9520.046
Fasting glucose (mmol/L)5.4 (0.02)5.5 (0.03)5.2 (0.04)5.6 (0.04)0.2 (0.1 to 0.3)<0.0010.0010.0820.432
30 min glucose (mmol/L)8.5 (0.1)8.9 (0.1)8.5 (0.1)8.7 (0.1)−0.2 (−0.4 to 0.01)0.0590.0990.0610.106
2-hour glucose (mmol/L)5.3 (0.1)5.9 (0.1)5.2 (0.1)5.5 (0.1)−0.3 (−0.5 to −0.01)0.0380.0660.3980.962
AUC glucose890.7 (4.96)937.9 (7)881 (8.7)912.5 (10.5)−19.1 (−39.1 to 0.9)0.0620.110.1190.33
Fasting insulin (mmol/L)7.7 (0.2)9.2 (0.2)7.9 (0.6)7.8 (0.3)−1.6 (−2.4 to −0.79)<0.001<0.0010.0080.591
30 min insulin (mmol/L)63.6 (1.5)76.5 (3)70.8 (2.5)73.5 (3.2)−9.6 (−15.6 to −3.7)0.0020.0030.8690.443
2-hour insulin (mmol/L)37.2 (1.4)47.9 (2.1)34.2 (1.9)37.9 (2.0)−8.4 (−13.5 to −3.3)0.0010.0020.4430.294
AUC insulin (103)5.7 (0.13)6.96 (6.0)6.0 (0.2)6.23 (0.24)−1.04 (−1.54 to −0.55)<0.001<0.0010.510.321
ISI142.4 (3.31)120.3 (3)139.1 (5)134.5 (5.4)16.9 (6.6 to 27.2)0.0010.0030.0570.841
CIR198.2 (8.01)208.9 (6.9)241.8 (16.8)207.7 (16.7)−16.4 (−50.1 to 17.2)0.3370.6230.1870.056
DI (103)25.2 (1.16)23.44 (1.12)31.5 (2.78)24.56 (3.13)−0.17 (−6.36 to 6.03)0.9580.7020.0340.108
HOMA-IR1.8 (0.05)2.3 (0.1)1.9 (0.2)2.0 (0.1)−0.4 (−0.6 to −0.1)0.0030.0080.0040.693
  • FH+=family history of diabetes.

  • *Propensity score weighted estimated means.

  • †Adjusted for baseline value and family history of diabetes.

  • AUC, area under the curve; BP, blood pressure; CIR, corrected insulin response; DI, disposition index; FH, family history of type 2 diabetes; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment for insulin resistance; ISI, insulin sensitivity index; LDL, low-density lipoprotein.